Crinetics Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Crinetics Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $45M, a 3492% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $45M +$43.8M +3492% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $45.8M +$44.4M +3238% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $46.5M +$45.1M +3033% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $48M +$46.4M +2914% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.25M -$444K -26.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.37M -$426K -23.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.49M -$406K -21.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $1.59M -$389K -19.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.7M -$372K -18% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.8M -$355K -16.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.89M -$340K -15.2% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.98M -$323K -14% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $2.07M -$308K -13% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $2.15M -$293K -12% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.23M -$278K -11.1% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.31M -$264K -10.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $2.38M -$250K -9.52% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $2.45M -$238K -8.87% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.51M Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.57M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.63M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $2.68M Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.